位置:首页 > 蛋白库 > SEM5A_MOUSE
SEM5A_MOUSE
ID   SEM5A_MOUSE             Reviewed;        1077 AA.
AC   Q62217;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-MAY-2022, entry version 146.
DE   RecName: Full=Semaphorin-5A;
DE   AltName: Full=Semaphorin-F;
DE            Short=Sema F;
DE   Flags: Precursor;
GN   Name=Sema5a; Synonyms=Semaf, SemF;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=NMRI;
RX   PubMed=8817451; DOI=10.1016/0925-4773(96)00525-4;
RA   Adams R.H., Betz H., Pueschel A.W.;
RT   "A novel class of murine semaphorins with homology to thrombospondin is
RT   differentially expressed during early embryogenesis.";
RL   Mech. Dev. 57:33-45(1996).
RN   [2]
RP   DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=15743826; DOI=10.1128/mcb.25.6.2310-2319.2005;
RA   Fiore R., Rahim B., Christoffels V.M., Moorman A.F., Puschel A.W.;
RT   "Inactivation of the Sema5a gene results in embryonic lethality and
RT   defective remodeling of the cranial vascular system.";
RL   Mol. Cell. Biol. 25:2310-2319(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=19850054; DOI=10.1016/j.mvr.2009.10.005;
RA   Sadanandam A., Rosenbaugh E.G., Singh S., Varney M., Singh R.K.;
RT   "Semaphorin 5A promotes angiogenesis by increasing endothelial cell
RT   proliferation, migration, and decreasing apoptosis.";
RL   Microvasc. Res. 79:1-9(2010).
RN   [4]
RP   DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=21835343; DOI=10.1016/j.neuron.2011.06.009;
RA   Matsuoka R.L., Chivatakarn O., Badea T.C., Samuels I.S., Cahill H.,
RA   Katayama K., Kumar S.R., Suto F., Chedotal A., Peachey N.S., Nathans J.,
RA   Yoshida Y., Giger R.J., Kolodkin A.L.;
RT   "Class 5 transmembrane semaphorins control selective Mammalian retinal
RT   lamination and function.";
RL   Neuron 71:460-473(2011).
CC   -!- FUNCTION: Bifunctional axonal guidance cue regulated by sulfated
CC       proteoglycans; attractive effects result from interactions with heparan
CC       sulfate proteoglycans (HSPGs), while the inhibitory effects depend on
CC       interactions with chondroitin sulfate proteoglycans (CSPGs). Ligand for
CC       receptor PLXNB3. In glioma cells, SEMA5A stimulation of PLXNB3 results
CC       in the disassembly of F-actin stress fibers, disruption of focal
CC       adhesions and cellular collapse as well as inhibition of cell migration
CC       and invasion through ARHGDIA-mediated inactivation of RAC1 (By
CC       similarity). May promote angiogenesis by increasing endothelial cell
CC       proliferation and migration and inhibiting apoptosis. {ECO:0000250,
CC       ECO:0000269|PubMed:19850054}.
CC   -!- SUBUNIT: Binds PLXNB3. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: In adult, detected in liver, brain, kidney, heart,
CC       lung and spleen.
CC   -!- DEVELOPMENTAL STAGE: Differentially expressed in embryonic and adult
CC       tissues. Its abundance decreases from 10 dpc to birth. At 10.5 dpc,
CC       detected in the atrial septum and endocardial cushions, and at lower
CC       levels in the atrial and ventricular endocardium. Strong expression
CC       detected in embryonic and postnatal retina. At P0 and P3, expression
CC       detected in the outer neuroblastic layer. After P7, the expression
CC       becomes more restricted and is observed in the middle to outer part of
CC       inner nuclear layer, and is not detectable at P21 when retinal
CC       development is almost complete. {ECO:0000269|PubMed:15743826,
CC       ECO:0000269|PubMed:21835343}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice die between 11.5 and 12.5 dpc. At
CC       this stage, no defects are detected in the development of
CC       extraembryonic tissues, cardiovascular system, axonal trajectories and
CC       peripheral nervous system. Mutants display decreased complexity of the
CC       hierarchically organized branches of the cranial blood vessels
CC       (PubMed:15743826). Mutant mice are viable and fertile
CC       (PubMed:21835343). {ECO:0000269|PubMed:15743826,
CC       ECO:0000269|PubMed:21835343}.
CC   -!- SIMILARITY: Belongs to the semaphorin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X97817; CAA66397.1; -; mRNA.
DR   AlphaFoldDB; Q62217; -.
DR   SMR; Q62217; -.
DR   STRING; 10090.ENSMUSP00000069024; -.
DR   GlyGen; Q62217; 10 sites.
DR   iPTMnet; Q62217; -.
DR   PhosphoSitePlus; Q62217; -.
DR   MaxQB; Q62217; -.
DR   PaxDb; Q62217; -.
DR   PeptideAtlas; Q62217; -.
DR   PRIDE; Q62217; -.
DR   ProteomicsDB; 256944; -.
DR   MGI; MGI:107556; Sema5a.
DR   eggNOG; KOG3611; Eukaryota.
DR   InParanoid; Q62217; -.
DR   PhylomeDB; Q62217; -.
DR   Reactome; R-MMU-416700; Other semaphorin interactions.
DR   Reactome; R-MMU-5173214; O-glycosylation of TSR domain-containing proteins.
DR   ChiTaRS; Sema5a; mouse.
DR   PRO; PR:Q62217; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q62217; protein.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0008046; F:axon guidance receptor activity; IDA:MGI.
DR   GO; GO:0045499; F:chemorepellent activity; IBA:GO_Central.
DR   GO; GO:0035373; F:chondroitin sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0030215; F:semaphorin receptor binding; IPI:UniProtKB.
DR   GO; GO:0045545; F:syndecan binding; ISS:UniProtKB.
DR   GO; GO:0048675; P:axon extension; IGI:MGI.
DR   GO; GO:0007411; P:axon guidance; IMP:MGI.
DR   GO; GO:0007413; P:axonal fasciculation; ISS:UniProtKB.
DR   GO; GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IDA:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IMP:MGI.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:MGI.
DR   GO; GO:0060326; P:cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IGI:MGI.
DR   GO; GO:0021536; P:diencephalon development; ISS:UniProtKB.
DR   GO; GO:0048843; P:negative regulation of axon extension involved in axon guidance; ISS:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; IBA:GO_Central.
DR   GO; GO:1990138; P:neuron projection extension; IDA:MGI.
DR   GO; GO:0097485; P:neuron projection guidance; IGI:MGI.
DR   GO; GO:0050918; P:positive chemotaxis; IDA:UniProtKB.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISS:UniProtKB.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0090091; P:positive regulation of extracellular matrix disassembly; NAS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; IDA:UniProtKB.
DR   GO; GO:1990256; P:signal clustering; IDA:UniProtKB.
DR   CDD; cd11263; Sema_5A; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.20.100.10; -; 6.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR042821; Sema5A_sema.
DR   InterPro; IPR001627; Semap_dom.
DR   InterPro; IPR036352; Semap_dom_sf.
DR   InterPro; IPR027231; Semaphorin.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR11036; PTHR11036; 1.
DR   Pfam; PF01403; Sema; 1.
DR   Pfam; PF00090; TSP_1; 5.
DR   SMART; SM00423; PSI; 1.
DR   SMART; SM00630; Sema; 1.
DR   SMART; SM00209; TSP1; 6.
DR   SUPFAM; SSF101912; SSF101912; 1.
DR   SUPFAM; SSF82895; SSF82895; 6.
DR   PROSITE; PS51004; SEMA; 1.
DR   PROSITE; PS50092; TSP1; 6.
PE   2: Evidence at transcript level;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Membrane; Neurogenesis; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1077
FT                   /note="Semaphorin-5A"
FT                   /id="PRO_0000032336"
FT   TOPO_DOM        22..971
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        972..992
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        993..1077
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          35..484
FT                   /note="Sema"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DOMAIN          540..593
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          595..651
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          653..702
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          707..765
FT                   /note="TSP type-1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          784..839
FT                   /note="TSP type-1 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          841..896
FT                   /note="TSP type-1 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          897..944
FT                   /note="TSP type-1 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   CARBOHYD        147
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        227
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        277
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        323
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        536
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        717
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        933
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        104..114
FT                   /evidence="ECO:0000250"
FT   DISULFID        131..140
FT                   /evidence="ECO:0000250"
FT   DISULFID        254..357
FT                   /evidence="ECO:0000250"
FT   DISULFID        278..320
FT                   /evidence="ECO:0000250"
FT   DISULFID        487..504
FT                   /evidence="ECO:0000250"
FT   DISULFID        496..513
FT                   /evidence="ECO:0000250"
FT   DISULFID        607..644
FT                   /evidence="ECO:0000250"
FT   DISULFID        611..650
FT                   /evidence="ECO:0000250"
FT   DISULFID        622..634
FT                   /evidence="ECO:0000250"
FT   DISULFID        665..696
FT                   /evidence="ECO:0000250"
FT   DISULFID        669..701
FT                   /evidence="ECO:0000250"
FT   DISULFID        680..686
FT                   /evidence="ECO:0000250"
FT   DISULFID        796..833
FT                   /evidence="ECO:0000250"
FT   DISULFID        800..838
FT                   /evidence="ECO:0000250"
FT   DISULFID        811..823
FT                   /evidence="ECO:0000250"
FT   DISULFID        853..890
FT                   /evidence="ECO:0000250"
FT   DISULFID        857..895
FT                   /evidence="ECO:0000250"
FT   DISULFID        868..880
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1077 AA;  120826 MW;  EDAB0DDDA42789FF CRC64;
     MKGACILAWL FSSLGVWRLA RPETQDPAKC QRAEHPVVSY KEIGPWLREF RAENAVDFSR
     LTFDPGQKEL VVGARNYLFR LELEDLSLIQ AVEWECDEAT KKACYSKGKS KEECQNYIRV
     LLVGGDRLFT CGTNAFTPVC TIRSLSNLTE IHDQISGMAR CPYSPQHNST ALLTASGELY
     AATAMDFPGR DPAIYRSLGT LPPLRTAQYN SKWLNEPNFV SSYDIGNFTY FFFRENAVEH
     DCGKTVFSRP ARVCKNDIGG RFLLEDTWTT FMKARLNCSR PGEVPFYYNE LQGTFFLPEL
     DLIYGIFTTN VNSIASSAVC VFNLSAISQA FNGPFKYQEN SRSAWLPYPN PNPNFQCGTM
     DQGLYVNLTE RNLQDAQKFI LMHEVVQPVT TVPSFMEDNS RFSHLAVDVV QGRETLVHII
     YLGTDYGTIK KVRAPLSQSS GSCLLEEIEL FPERRSEPIR SLQILHSQSV LFVGLQEHVA
     KIPLKRCHFH QTRSACIGAQ DPYCGWDAVM KKCTSLEESL SMTQWDQSIP TCPTRNLTVD
     GSFGPWSPWT PCTHTDGTAV GSCLCRSRSC DRPAPQCGGW QCEGPRMEIT NCSRNGGWTP
     WTSWSPCSTT CGIGFQVRQR SCSNPTPRHG GRVCVGQNRE ERYCNEHLLC PPHVFWTGWG
     PWERCTAQCG GGIQARRRTC ENGPDCAGSN VEYHPCNTNA CPELKKTTPW TPWTPVNISD
     NGGHYEQRFR YTCKARLPDP NLLEVGRQRI EMRYCSSDGT SGCSTDGLSG DFLRAGRYSA
     HTVNGAWSAW TSWSQCSRDC SRGIRNRKRV CNNPEPKFGG MPCLGPSLEF QECNILPCPV
     DGVWSCWSSW SKCSATCGGG HYMRTRSCSN PAPAYGGDIC LGLHTEEALC NTQTCPESWS
     EWSDWSVCDA SGTQVRARQC ILLFPVGSQC SGNTTESRPC VFDSNFIPEV SVARSSSVEE
     KRCGEFNMFH MFHMMAVGLS SSILGCLLTL LVYTYCQRYQ QQSHDATVIH PVSPAALNSS
     ITNHINKLDK YDSVEAIKAF NKNNLILEER NKYFNPHLTG KTYSNAYFTD LNNYDEY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024